Mathilde Lemoine

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Diagnostic yield of hypertension evaluation in a nephrology day hospital

Diagnostic yield of hypertension evaluation in a nephrology day hospital

Journal: Nephrologie & therapeutique

Published: April 28, 2026

Optimizing HLA desensitization: serum dilution strategies and platform-specific MFI thresholds for antibody-mediated rejection risk in kidney transplantation.

Optimizing HLA desensitization: serum dilution strategies and platform-specific MFI thresholds for antibody-mediated rejection risk in kidney transplantation.

Journal: Frontiers in immunology

Published: July 08, 2025

Kidney Transplant Recipients Switching to Prolonged-Release Tacrolimus: Five-Year Real-World Clinical Outcomes From the CHORUS Study

Kidney Transplant Recipients Switching to Prolonged-Release Tacrolimus: Five-Year Real-World Clinical Outcomes From the CHORUS Study

Journal: Annals of transplantation

Published: June 24, 2025

Biopsy-based transcriptomics in kidney transplantation: Where do we stand in 2025?

Biopsy-based transcriptomics in kidney transplantation: Where do we stand in 2025?

Journal: Nephrologie & therapeutique

Published: June 11, 2025

One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection.

One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection.

Journal: Clinical kidney journal

Published: May 07, 2025

Improving propulsive efficiency using bio-inspired intermittent locomotion.

Improving propulsive efficiency using bio-inspired intermittent locomotion.

Journal: Journal of the Royal Society, Interface

Published: January 21, 2025

Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation.

Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation.

Journal: Kidney international reports

Published: September 20, 2024

Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study.

Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: July 16, 2024

Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study.

Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study.

Journal: Clinical transplantation

Published: February 13, 2024

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose.

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose.

Journal: Microorganisms

Published: January 22, 2024

Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?

Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?

Journal: Viruses

Published: January 03, 2024

Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients.

Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 29, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026